ClinicalTrials.govpublic full text
Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients
end stage renal disease on dialysis, peritoneal dialysis complication, sodium-glucose cotransporter-2 inhibitor, residual kidney function
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 123658
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.